Exploring the Research on 5-MeO-DMT
At Enfold, we are committed to staying informed on the latest scientific research regarding 5-MeO and its therapeutic benefits.
The growing body of research on 5-MeO-DMT highlights its profound potential for addressing PTSD, depression, anxiety, and addiction, with promising safety and neurobiological benefits. Below, we highlight key studies that provide insight into its effects on mental health, neurogenesis, safety, and therapeutic applications.
5-MeO for PTSD
A Real-World Longitudinal Case Study
- This study presents the first longitudinal case on 5-MeO for chronic, refractory PTSD in a 23-year-old female.
- A single dose of vaporized bufotoxin (containing 10–15 mg of 5-MeO) led to significant improvements in PTSD symptoms, including reduced hopelessness and suicide risk.
- The participant reported a complete mystical experience, which may contribute to 5-MeO’s therapeutic effects.
- Benefits were sustained at 1, 3, 6, and 12 months.
Depression and Anxiety
Fast-Acting Psychedelic Effects
- A survey of 362 adults found that approximately 80% reported reduced anxiety and depression after 5-MeO use.
- Positive outcomes correlated with mystical experiences and increased personal meaning.
Treatment-Resistant Depression
Phase 1/2 Trial of Vaporized 5-MeO (GH001)
- A study of 16 patients with treatment-resistant depression found that individualized dosing (up to three doses in one day) provided ultra-rapid antidepressant effects.
Safety and Tolerability
Short-Term Safety Profile in Clinical Trials
- A systematic review found that 5-MeO has a favourable short-term safety profile.
- No serious adverse events (SAEs) were documented, and no participants withdrew due to side effects.
Neurogenesis and Cellular Benefits
A Single Dose Stimulates Brain Growth and Immunomodulation
- Research indicates that 5-MeO promotes neurogenesis, enhances neuron survivability, and supports the immune system.
Biological and Psychological Effects
Effects on Inflammation, Cortisol, and Well-Being
- A study examining vaporized synthetic 5-MeO found reductions in inflammatory markers, improved mood, and increased non-judgmental awareness.
Alcohol Use Disorder
Study of Intranasal 5-MeO
- A single dose led to significant and sustained reductions in alcohol consumption.
- 50% of patients maintained complete abstinence over three months, with heavy drinking days reduced from 56% to 13%.
Comparing 5-MeO to Other Psychedelics
Narrative Review of Research
- Findings suggest that 5-MeO has a risk profile similar to psilocybin, with high rates of ego-dissolution and mystical experiences.
- These effects correlate with long-term therapeutic benefits, supporting further clinical exploration.